Voyager Therapeutics, Inc.
Overview
Voyager Therapeutics, Inc. is a gene therapy company developing treatments for severe neurological diseases. The company is focused on leveraging its AAV capsid discovery platform, TRACER, to advance its pipeline of novel, targeted therapies.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Voyager Therapeutics, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.